Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-175255
Filing Date
2017-05-18
Accepted
2017-05-18 16:04:57
Documents
14
Period of Report
2017-06-15
Effectiveness Date
2017-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d370403ddef14a.htm DEF 14A 561137
2 GRAPHIC g370403g81p13.jpg GRAPHIC 36046
3 GRAPHIC g370403pc01a.jpg GRAPHIC 26112
4 GRAPHIC g370403pc01b.jpg GRAPHIC 3035
5 GRAPHIC g370403pc01c.jpg GRAPHIC 2926
6 GRAPHIC g370403pc01d.jpg GRAPHIC 44219
7 GRAPHIC g370403pc01e.jpg GRAPHIC 2884
8 GRAPHIC g370403pc01f.jpg GRAPHIC 1979
9 GRAPHIC g370403pc01g.jpg GRAPHIC 2523
10 GRAPHIC g370403pc01h.jpg GRAPHIC 14751
11 GRAPHIC g370403pc01i.jpg GRAPHIC 12348
12 GRAPHIC g370403pc02a.jpg GRAPHIC 2568
13 GRAPHIC g370403pc02b.jpg GRAPHIC 2499
14 GRAPHIC g370403pc02c.jpg GRAPHIC 2495
  Complete submission text file 0001193125-17-175255.txt   770096
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51173 | Film No.: 17854953
SIC: 2834 Pharmaceutical Preparations